Parapharyngeal Space Tumors Workup

  • Author: Christine G Gourin, MD, FACS; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Jul 1, 2011
 

Laboratory Studies

  • Twenty-four–hour urine collection for catecholamines: Although functioning tumors are rare, if a secreting paraganglioma is suspected, obtain a 24-hour urine collection for catecholamines to screen for a secreting lesion. If catecholamine level results are positive, perform a metaiodobenzylguanidine (MIBG) scan (see MIBG scanning).
  • Vanillylmandelic acid (VMA), or 4-hydroxy-3-methoxymandelic acid
  • Metanephrine
Next

Imaging Studies

  • Radiologic studies are essential in the evaluation of a patient with a suspected parapharyngeal space (PPS) mass. Performing these studies before considering biopsy is important because, given the differential diagnosis of a parapharyngeal space (PPS) lesion, one can often make a diagnosis on the basis of imaging studies without the need for fine-needle aspiration biopsy (FNAB) or open biopsy.
    • Imaging studies should answer the following questions:
      • Is the mass prestyloid or poststyloid?
      • What is the relationship to the parotid gland?
      • What is the relationship to the great vessels?
      • What are the soft tissue characteristics of the tumor?
    • The differential diagnosis of a parapharyngeal space (PPS) mass can be greatly narrowed by determining whether the mass arises from the deep lobe of the parotid and whether the mass originates in the prestyloid or poststyloid space. The parapharyngeal fat pad is located in the prestyloid space. Prestyloid lesions cause medial displacement of the parapharyngeal fat pad and are located anterior to the great vessels. Poststyloid lesions displace the parapharyngeal fat pad anteriorly and laterally, between the mass and the pterygoid muscles.
    • Computed tomography (CT) scanning and magnetic resonance imaging (MRI) have equal efficacy in localizing the lesion to the prestyloid or poststyloid space as seen in the images below. Both studies have advantages and disadvantages when compared to each other. CT scanning or MRI is used as a starting point in the evaluation of a parapharyngeal space (PPS) mass, and, sometimes, only 1 test may be needed. Angiography is reserved for enhancing lesions. Ultrasonography does not provide adequate resolution of the parapharyngeal space (PPS) and is not indicated in the workup of parapharyngeal space (PPS) lesions. CT scan of prestyloid space mass. The lesion causeCT scan of prestyloid space mass. The lesion causes medial displacement of the parapharyngeal fat pad and represents a benign salivary gland tumor. MRI of a poststyloid mass. Note anterior displacemMRI of a poststyloid mass. Note anterior displacement of the parapharyngeal fat and multiple flow voids within the tumor itself, consistent with a diagnosis of paraganglioma.
  • CT scanning
    • CT scanning can localize a parapharyngeal space (PPS) mass to the prestyloid or poststyloid space. It may also demonstrate whether the mass arises from the deep lobe of the parotid; a fat plane between the parotid and the mass suggests an extraparotid origin.
    • CT scanning is superior to MRI in demonstrating the presence of calcifications and bony involvement.
    • With contrast infusion, the relationship of the mass to the great vessels may be appreciated, although enhanced poststyloid lesions may be difficult to separate from the carotid artery.
    • CT scanning is inferior to MRI in delineating soft tissue characteristics of the tumor, particularly in large lesions in which the tumor margin may be difficult to distinguish from the fascia of adjacent musculature. CT scanning also carries the risk of exposure to ionizing radiation and intravenous contrast. Nevertheless, CT scanning remains widely used because of its wide availability and lower cost. CT scanning may be the only study required because most parapharyngeal space (PPS) masses are prestyloid lesions arising from the parotid gland. Because of its superior soft tissue and vascular resolution, a subsequent MRI is recommended to further evaluate all poststyloid masses or, if malignancy is suspected, to evaluate the extent of malignancy and to rule out intracranial extension.
  • Magnetic resonance imaging
    • MRI is superior to CT scanning in its ability to ascertain the soft tissue characteristics of parapharyngeal space (PPS) tumors. MRI can be used to differentiate between tumor and muscle, and it has greater resolution in defining the great vessels and their relationship to tumor. Intracranial extension is better delineated on MRI.
    • The diagnosis can often be made on the basis of characteristic MRI findings. Paragangliomas have been described as having a "salt-and-pepper" appearance on MRI because of numerous flow voids within the lesion. Schwannomas show greater enhancement on T2-weighted images, enhance with gadolinium, and lack flow voids.
    • MRI scanning is probably the screening test of choice to evaluate a parapharyngeal space (PPS) lesion because of the greater soft tissue resolution and vascular information obtained. However, its cost is significantly greater, the ability to determine bone involvement is poor, and it may be contraindicated in certain patients (eg, those with pacemakers, those with certain hardware, those who are claustrophobic).
    • The information obtained from both CT scanning and MRI is complementary, and both studies should be performed in the evaluation of extensive lesions or when malignancy is suspected.
  • Angiography
    • Angiography is recommended in the workup of most vascular lesions. Angiography is also used if malignancy is suspected and if carotid sacrifice is possible during resection. If carotid resection is considered, angiography is combined with balloon occlusion testing to measure cerebral blood flow (see Balloon occlusion test in Other Tests).
    • Angiography is useful in the evaluation of poststyloid lesions to demonstrate their relationship to the great vessels and to distinguish between neurogenic and vascular lesions; however, this distinction can usually be made with MRI.
    • Findings on angiography may be diagnostic of neurogenic lesions. Carotid body tumors are usually located at the bifurcation and cause splaying of the carotid bifurcation, called the lyre sign as seen in the image below. Angiogram of carotid body tumor. These are found bAngiogram of carotid body tumor. These are found between the carotid bifurcation and cause splaying of the internal carotid artery and external carotid artery resulting in the lyre sign.
      • Glomus vagale tumors, because of their association with the vagus nerve, lie laterally and posteriorly to the carotid system, displacing this anteriorly and medially as seen in the image below. Angiogram of glomus vagale tumor. Because the vaguAngiogram of glomus vagale tumor. Because the vagus nerve lies laterally and posteriorly to the carotid system, these appear as vascular lesions displacing the internal carotid artery and external carotid artery anteriorly and medially.
    • Schwannomas appear as avascular masses displacing the carotid system anteriorly. Metastases (eg, renal cell carcinoma) often appear quite vascular if they take their blood supply from the external carotid. Most vascular lesions should be evaluated with angiography to delineate their extent and blood supply; feeding vessels may be identified and may be embolized preoperatively to facilitate resection.
    • CT angiography and magnetic resonance (MR) angiography are emerging as alternatives to conventional arteriography. These tests are becoming more widely used, but they may relegate conventional arteriography to those instances in which the blood supply remains in question, balloon occlusion is required, or embolization is being considered.
Previous
Next

Other Tests

  • Balloon occlusion test
    • The balloon occlusion test measures the effect of internal carotid artery occlusion on cerebral blood flow (CBF) and the adequacy of the contralateral circulation. It is indicated when findings on imaging studies suggest carotid involvement or when resection of the lesion carries a high risk of intraoperative carotid artery injury.
    • Angiography is performed, and the internal carotid artery is occluded for 10-15 minutes using a balloon-tipped catheter. In patients who develop neurologic symptoms (approximately 5% of patients), the test is abandoned, and no further evaluation is performed. These patients are considered at high risk for stroke and should undergo nonoperative therapy, subtotal resection with carotid preservation, or revascularization prior to resection. In some settings, blood flow can be quantitated using substances such as xenon.
    • In patients without neurologic symptoms during balloon occlusion, xenon-enhanced CT scanning is performed to quantitate CBF. CBF is evaluated both before and after balloon occlusion; xenon gas is inhaled, it diffuses rapidly into the bloodstream, and it causes perfused areas of the brain to become radiopaque. Patients with diminished perfusion on xenon-enhanced CT scanning (approximately 25% of patients) are considered at mild-to-moderate risk of stroke with prolonged carotid occlusion. Interposition grafting of the internal carotid artery is recommended if the artery is to be sacrificed.
    • A 4% risk of neurologic sequelae exists from the balloon occlusion test itself, so the procedure is reserved only for cases in which the carotid is suspected to be involved or at risk.
  • MIBG scanning: If screening for a functional paraganglioma by urinary VMA and metanephrine levels is positive, obtain an MIBG scan. This radioisotope has a similar molecular structure to norepinephrine and is used to trace catecholamine uptake and storage.
  • Metastatic workup: If a metastatic lesion is suspected, the primary tumor should be sought by performing a full clinical evaluation, panendoscopy, and a full metastatic workup as directed by the clinical examination findings.
Previous
Next

Diagnostic Procedures

  • Biopsy
    • Under most circumstances, a presumptive diagnosis can be made on the basis of the findings of the imaging studies described above. Under no circumstances should biopsy of a parapharyngeal space (PPS) mass be performed prior to obtaining results from the radiologic studies. Complete surgical excision is the mainstay of treatment and is recommended for both diagnostic and therapeutic purposes.
    • FNAB may be a useful adjunct when the mass is readily accessible, either transcervically or transorally, and may provide useful information if a diagnosis of malignancy is suspected. However, if imaging studies suggest a vascular lesion, FNAB provides little if any useable information and is not indicated.
    • Incisional biopsy should be considered only if the patient is not an operative candidate and FNAB findings are inconclusive and if a diagnosis of malignancy or lymphoma is strongly suspected.
    • Transoral open biopsy has been described but carries a significant risk of hemorrhage and of contamination of the pharyngeal mucosa by tumor, which requires excision of that site during subsequent definitive resection. Most surgeons, including the authors, denounce this practice.
Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

Christine G Gourin, MD, FACS  Associate Professor, Director of Clinical Reasearch Program in Head and Neck Cancer, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University

Christine G Gourin, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American College of Surgeons Oncology Group, American Head and Neck Society, Association of Women Surgeons, Phi Beta Kappa, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society

Disclosure: Nothing to disclose.

Coauthor(s)

Jonas T Johnson, MD, FACS  Chairman, Department of Otolaryngology, The Eugene N Myers, MD, Professor and Chairman of Otolaryngology, Professor, Department of Radiation Oncology, University of Pittsburgh School of Medicine; Professor, Department of Oral Maxillofacial Surgery, University of Pittsburgh School of Dental Medicine

Jonas T Johnson, MD, FACS is a member of the following medical societies: Allegheny County Medical Society, American Academy of Otolaryngology-Head and Neck Surgery, American Association for Cancer Research, American Bronchoesophagological Association, American College of Surgeons, American Head and Neck Society, American Laryngological Association, American Laryngological Rhinological and Otological Society, American Medical Association, American Radium Society, American Rhinologic Society, American Society of Clinical Oncology, Pennsylvania Medical Society, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

William M Lydiatt, MD  Professor and Division Director, Head and Neck Surgical Oncology, Department of Otolaryngology-Head and Neck Surgery, University of Nebraska Medical Center

William M Lydiatt, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, and Nebraska Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Erik Kass, MD  Chief, Department of Clinical Otolaryngology, Associates in Otolaryngology of Northern Virginia

Erik Kass, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Association for Cancer Research, American Medical Association, and American Rhinologic Society

Disclosure: Nothing to disclose.

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

References

  1. Suarez-Fente V, Llorente-Pendas JL, Gomez-Martinez J, Garcia-Gonzalez LA, Lopez-Alvarez F, Suarez-Nieto C. [Primary tumours of the parapharyngeal space. Our experience in 51 patients.]. Acta Otorrinolaringol Esp. Jan 2009;60(1):19-24. [Medline].

  2. Baysal BE, Farr JE, Rubinstein WS, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet. Jan 1997;60(1):121-32. [Medline].

  3. Batsakis JG, Sneige N. Parapharyngeal and retropharyngeal space diseases. Ann Otol Rhinol Laryngol. Apr 1989;98(4 Pt 1):320-1. [Medline].

  4. Carrau RL, Myers EN, Johnson JT. Management of tumors arising in the parapharyngeal space. Laryngoscope. Jun 1990;100(6):583-9. [Medline].

  5. Christopoulos E, Carrau R, Segas J, Johnson JT, Myers EN, Wagner RL. Transmandibular approaches to the oral cavity and oropharynx. A functional assessment. Arch Otolaryngol Head Neck Surg. Nov 1992;118(11):1164-7. [Medline].

  6. Curtin HD. Separation of the masticator space from the parapharyngeal space. Radiology. Apr 1987;163(1):195-204. [Medline].

  7. Eisele DE, Netterville JL, Hoffman HT, Gantz BJ. Parapharyngeal space masses. Head Neck. Mar 1999;21(2):154-9. [Medline].

  8. Gluckman J. Parapharyngeal space. In: Gluckman J, Gullane P, Johnson J, eds. Practical Approach to Head and Neck Tumors. New York, NY: Raven Press; 1994:33-46.

  9. Hamza A, Fagan JJ, Weissman JL, Myers EN. Neurilemomas of the parapharyngeal space. Arch Otolaryngol Head Neck Surg. Jun 1997;123(6):622-6. [Medline].

  10. Hughes KV 3rd, Olsen KD, McCaffrey TV. Parapharyngeal space neoplasms. Head Neck. Mar-Apr 1995;17(2):124-30. [Medline].

  11. Leonetti JP, Donzelli JJ, Littooy FN, Farrell BP. Perioperative strategies in the management of carotid body tumors. Otolaryngol Head Neck Surg. Jul 1997;117(1):111-5. [Medline].

  12. McCaffrey TV, Meyer FB, Michels VV, Piepgras DG, Marion MS. Familial paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg. Nov 1994;120(11):1211-6. [Medline].

  13. Myers EN, Johnson JT, Curtin HD. Tumors of the Parapharyngeal Space. In: Myers EN, Suen JY, eds. Cancer of the Head and Neck. 3rd ed. Philadelphia, Pa: WB Saunders; 1996:562-585.

  14. Olsen KD. Tumors and surgery of the parapharyngeal space. Laryngoscope. May 1994;104(5 Pt 2 Suppl 63):1-28. [Medline].

  15. Pensak ML, Gluckman JL, Shumrick KA. Parapharyngeal space tumors: an algorithm for evaluation and management. Laryngoscope. Sep 1994;104(9):1170-3. [Medline].

  16. Pitman KT, Weissman JL, Johnson JT. The parapharyngeal space: diagnosis and management of commonly encountered entities. In: Self-instructional package (SIPac). 3rd ed. Rochester, NY: The American Academy of Otolaryngology-Head and Neck Surgery Foundation; 1998:1-66.

  17. Saito DM, Glastonbury CM, El-Sayed IH, Eisele DW. Parapharyngeal space schwannomas: preoperative imaging determination of the nerve of origin. Arch Otolaryngol Head Neck Surg. Jul 2007;133(7):662-7. [Medline].

  18. Schwaber MK, Glasscock ME, Nissen AJ, Jackson CG, Smith PG. Diagnosis and management of catecholamine secreting glomus tumors. Laryngoscope. Aug 1984;94(8):1008-15. [Medline].

  19. Som PM, Biller HF, Lawson W. Tumors of the parapharyngeal space: preoperative evaluation, diagnosis and surgical approaches. Ann Otol Rhinol Laryngol Suppl. Jan-Feb 1981;90(1 Pt 4):3-15. [Medline].

  20. Som PM, Curtin HD. Lesions of the parapharyngeal space. Role of MR imaging. Otolaryngol Clin North Am. Jun 1995;28(3):515-42. [Medline].

  21. Urquhart AC, Johnson JT, Myers EN, Schechter GL. Glomus vagale: paraganglioma of the vagus nerve. Laryngoscope. Apr 1994;104(4):440-5. [Medline].

 
Previous
Next
 
Parapharyngeal space tumor manifesting as an oropharyngeal mass.
Parapharyngeal space tumor manifesting as a neck mass.
CT scan of prestyloid space mass. The lesion causes medial displacement of the parapharyngeal fat pad and represents a benign salivary gland tumor.
T2-weighted MRI of a prestyloid space mass. This mass is confluent with the deep lobe of the parotid gland; the parapharyngeal fat pad is displaced medially. These findings are consistent with an origin from the deep lobe of the parotid.
CT scan of a poststyloid space mass. Note the anterior and lateral displacement of the parapharyngeal fat, characteristic of poststyloid lesions. This lesion enhances and proved to represent a carotid body tumor.
MRI of a poststyloid mass. Note anterior displacement of the parapharyngeal fat and multiple flow voids within the tumor itself, consistent with a diagnosis of paraganglioma.
Angiogram of carotid body tumor. These are found between the carotid bifurcation and cause splaying of the internal carotid artery and external carotid artery resulting in the lyre sign.
Angiogram of glomus vagale tumor. Because the vagus nerve lies laterally and posteriorly to the carotid system, these appear as vascular lesions displacing the internal carotid artery and external carotid artery anteriorly and medially.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.